|
Volumn 40, Issue 3, 1997, Pages 205-238
|
Thrombosis, antithrombotic agents, and the antithrombotic approach in cardiac disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABCIXIMAB;
ALTEPLASE;
ANTICOAGULANT AGENT;
CLOPIDOGREL;
COUMARIN ANTICOAGULANT;
ENOXAPARIN;
EPTIFIBATIDE;
FIBRINOGEN;
FIBRINOGEN RECEPTOR;
FIBRINOLYTIC AGENT;
HEPARIN;
HIRUDIN;
HIRULOG;
LAMIFIBAN;
SULFINPYRAZONE;
THROMBIN;
THROMBOCYTE SLOWING FACTOR;
TICLOPIDINE;
TIROFIBAN;
UNCLASSIFIED DRUG;
UROKINASE;
ACUTE HEART INFARCTION;
ANTICOAGULATION;
BLOOD CLOTTING;
ENDOTHELIUM CELL;
HEART ATRIUM FIBRILLATION;
HEART MUSCLE REVASCULARIZATION;
HEART VALVE PROSTHESIS;
HEMOSTASIS;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MITRAL VALVE STENOSIS;
REVIEW;
RISK ASSESSMENT;
RISK BENEFIT ANALYSIS;
SAPHENOUS VEIN;
SHEAR STRESS;
THROMBOEMBOLISM;
THROMBOSIS;
UNSTABLE ANGINA PECTORIS;
|
EID: 0031441628
PISSN: 00330620
EISSN: None
Source Type: Journal
DOI: 10.1016/S0033-0620(97)80035-7 Document Type: Article |
Times cited : (18)
|
References (197)
|